Services on Demand
- Cited by Google
- Similars in SciELO
- Similars in Google
Revista Brasileira de Otorrinolaringologia
Print version ISSN 0034-7299
PINHEIRO NETO, Carlos Diógenes; WEBER, Raimar; ARAUJO-FILHO, Bernardo Cunha and MIZIARA, Ivan Dieb. Rhinosinusitis in HIV-infected children undergoing antiretroviral therapy. Rev. Bras. Otorrinolaringol. [online]. 2009, vol.75, n.1, pp. 70-75. ISSN 0034-7299. http://dx.doi.org/10.1590/S0034-72992009000100011.
The association of protease inhibitors (PI) to antiretroviral therapy has generated sensible changes in morbidity and mortality of HIV-infected patients. AIM: Aims at evaluating the impact of this association on the prevalence of rhinosinusitis (RS) and CD4+ lymphocyte count in HIV-infected children. METHODS: Retrospective cross-sectional study of the medical charts of 471 HIV-infected children. In 1996, protease inhibitors were approved for use as an association drug in antiretroviral therapy. Children were divided into two groups: one which did not receive PI and another which received PI after 1996. The prevalence of RS and CD4+ lymphocyte counts were compared between these groups. RESULTS: 14.4% of HIV-infected children had RS. Chronic RS was more prevalent the its acute counterpart. Children under 6 years old who were taking protease inhibitors presented with a significant higher prevalence of acute RS. The association of PI with the antiretroviral regimen was associated to higher mean CD4+ lymphocyte count and lower prevalence of chronic RS. CONCLUSIONS: The use of protease inhibitors was associated to higher mean CD4+ lymphocyte count. Children under 6 years of age in antiretroviral therapy associated with PI presented a lower likelihood of developing chronic RS.
Keywords : children; haart; hiv infections; sinusitis.